Vergoeding 2020-2024 voor ATC-subgroep A02BA : H2-antagonisten
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| A02BA01 Cimetidine | 196.230 | 238.120 | 338.170 | 374.400 | 418.250 |
| A02BA02 Ranitidine | 1.056.500 | 878.100 | 785.550 | 699.870 | 423.720 |
| A02BA03 Famotidine | 1.773.400 | 3.283.400 | 5.086.600 | 6.737.300 | 8.090.800 |
| A02BA04 Nizatidine | 5.018 | 20 | . | . | . |
| Totaal | 3.031.148 | 4.399.640 | 6.210.320 | 7.811.570 | 8.932.770 |